These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16176888)

  • 1. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience.
    Bourgeois BF; D'Souza J
    Epilepsy Behav; 2005 Nov; 7(3):375-82. PubMed ID: 16176888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
    Martinez W; Ingenito A; Blakeslee M; Barkley GL; McCague K; D'Souza J
    Epilepsy Behav; 2006 Nov; 9(3):448-56. PubMed ID: 16962380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials.
    Beydoun A
    Pharmacotherapy; 2000 Aug; 20(8 Pt 2):152S-158S. PubMed ID: 10937814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine, an antiepileptic agent.
    Kalis MM; Huff NA
    Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
    Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
    Sachdeo R; Sathyan RR
    Curr Med Res Opin; 2005 Jul; 21(7):1065-8. PubMed ID: 16004674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine therapy in very young children: a single-center clinical experience.
    Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
    Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxcarbazepine in the treatment of epilepsy. A review and update].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
    Pauletto G; Bergonzi P;
    Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on oxcarbazepine in epilepsy.
    Bang LM; Goa KL
    CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine in the treatment of epilepsy.
    Glauser TA
    Pharmacotherapy; 2001 Aug; 21(8):904-19. PubMed ID: 11718497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Kowatch RA; Emslie GJ; Findling RL; Wilens TE; McCague K; D'Souza J; Wamil A; Lehman RB; Berv D; Linden D
    Am J Psychiatry; 2006 Jul; 163(7):1179-86. PubMed ID: 16816222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies.
    Wheless JW; Conry J; Krauss G; Mann A; LoPresti A; Narurkar M
    J Child Neurol; 2009 Dec; 24(12):1520-5. PubMed ID: 19955344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxcarbazepine].
    Arroyo S
    Neurologia; 2001 Oct; 16(8):370-5. PubMed ID: 11738014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
    Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
    J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
    Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
    Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.